Clinical disease progression and biomarkers in Niemann–Pick disease type C: a prospective cohort study
Efficacy and safety of arimoclomol in Niemann-Pick disease type C: Results from a double-blind, randomised, placebo-controlled, multinational phase 2/3 trial of a novel treatment March 1, 2023
Patterns of Abuse of Prescription Stimulant Products from the National Addictions Vigilance Intervention Program (NAVIPPRO): 2010-2018 January 26, 2023
News
Careers
Contacts
